Recent Updates
Recently added Catalysts
ATHE

APPENDIX 4D: INTERIM FINANCIAL REPORT ex99-1 -- Converted by SECPublisher 2.1.1.8, created by BCL Technologies Inc., for SEC Filing

Wednesday, February 18, 2009 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: APPENDIX 4D: INTERIM FINANCIAL REPORT ex99-1 -- Converted by SECPublisher 2.1.1.8, created by BCL Technologies Inc., for SEC Filing

Full Press Release Details

APPENDIX 4D: INTERIM FINANCIAL REPORT ex99-1 -- Converted by SECPublisher 2.1.1.8, created by BCL Technologies Inc., for SEC Filing
ShareAdd on Google
Tags: ATHE Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Feb 18, 2009

Biotech snapshot

Lead asset
ATH434Phase 2
Multiple System Atrophy →